Sort
261,768 grants matching “gene therapy”
Biomarkers of Developmental Trajectories and Treatment in ASD
$2,044,233Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2016 · HD
Epidemiology of Dementia in Cache County, Utah
$2,044,076Duke University · R01 · FY2002 · AG
Hyperactivity of the thalamo-hippocampal-prefrontal circuit as a mechanism for anxiety in Alzheimer disease - Resubmission - 1
$2,044,038Arjun Vijay Masurkar · New York University School Of Medicine · RF1 · FY2024 · AG
Molecular Biology Of Outer Retina-specific Proteins
$2,044,034Thomas M Redmond · National Eye Institute · Z01 · FY2008 · EY
SPORE IN OVARIAN CANCER
$2,043,985Fox Chase Cancer Center · P50 · FY2000 · CA
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2019 · AI
Regulation And Function Of Retroelements
$2,043,923Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Epitranscriptomics in human obesity and type 2 diabetes
$2,043,780Rohit N. Kulkarni · Joslin Diabetes Center · RC2 · FY2024 · DK
Papillomavirus Virion Proteins and Vaccines
$2,043,490John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
PET/MRI imaging of mitral valve prolapse
$2,043,200Maria Giovanna Trivieri · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
Molecular Genetics Support to Identify Gene/Environment Interactions in Disease
$2,042,935Richard Paules · National Institute Of Environmental Health Sciences · ZIC · FY2012 · ES
Genes And Gene Products As Immunoadjuvants
$2,042,766Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
SPORE in Brain Cancer
$2,042,322Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
EVALUATION OF THE IMMUNOGENICITY AND EFFICACY OF HIV-1 CLADE C OLIGOMERIC ENVELOPE PROTEIN DELIVERED WITH ADVAX DELTA INULIN ADJUVANT BY INTRAMUSCULAR AND INTRAPULMONARY ROUTES
$2,041,729Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Centers for Cancer Systems Therapeutics (CaST)
$2,041,589Andrea Califano · Columbia University Health Sciences · U54 · FY2020 · CA
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$2,041,466Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$2,041,466Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
$2,041,142John D Minna · Ut Southwestern Medical Center · P50 · FY2015 · CA
Center for Comparative Effectiveness Research in Cancer Genomics - CANCERGEN
$2,041,110Scott D Ramsey · Fred Hutchinson Cancer Research Center · RC2 · FY2009 · CA
Mechanisms of Breast Development and Carcinogenesis
$2,040,926Robert A Weinberg · Whitehead Institute For Biomedical Res · P01 · FY2009 · CA
Viral transmission and pathogenesis in human tissues
$2,040,457Leonid B. Margolis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Targeting the DNA damage response in cancer therapy
$2,040,170Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance
$2,039,977Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
Normal and Neoplastic Growth in the Brain
$2,039,886Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2017 · CA
Anatomic Pathology Residency Program
$2,039,628Frederic Barr · Division Of Basic Sciences - Nci · ZIE · FY2022 · CA